The biological impact of Rho depends critically on the precise subcellular localization of its active, GTP-loaded form. This can potentially be determined by the balance between molecules that promote nucleotide exchange or GTP hydrolysis. However, how these activities may be coordinated is poorly understood. We now report a molecular pathway that achieves exactly this coordination at the epithelial zonula adherens. We identify an extramitotic activity of the centralspindlin complex, better understood as a cytokinetic regulator, which localizes to the interphase zonula adherens by interacting with the cadherin-associated protein, α-catenin. Centralspindlin recruits the RhoGEF, ECT2, to activate Rho and support junctional integrity through myosin IIA. Centralspindlin also inhibits the junctional localization of p190 B RhoGAP, which can inactivate Rho. Thus, a conserved molecular ensemble that governs Rho activation during cytokinesis is used in interphase cells to control the Rho GTPase cycle at the zonula adherens.
Rho family GTPases are fundamental regulators of cell behaviour that are active in their GTP-loaded state 1 . This state is determined by the action of guanosine nucleotide exchange factors (GEFs) that catalyse GTP-loading, and GTPase-activating proteins (GAPs) that stimulate Rho proteins to convert bound GTP to GDP (refs 2,3) . The biological impact of Rho also depends on the precise subcellular site where Rho-GTP is expressed [4] [5] [6] [7] . This is exemplified by cytokinesis, where Rho accumulates at the contractile furrow and regulates actomyosin-based processes necessary for cell division 6, 8, 9 . Importantly, the precise spatio-temporal control of this Rho zone contributes to orderly cell division 3, 8 . Interphase epithelial cells concentrate Rho at their cell-cell junctions 5, 10 . Rho signalling is necessary for cell-cell integrity 11, 12 and this is probably mediated by the actomyosin cytoskeleton. Potential Rho effectors at junctions include non-muscle myosin II (ref. 13) and regulators of actin dynamics, such as formins 14 . However, the molecular mechanism that controls Rho-GTP at junctions is poorly understood. Formally, coordinate regulation of the GEF and GAP limbs of its GTPase cycle can control the spatial expression of the Rho-GTP signal 3, 12 . However, for this to occur there must be mechanisms that spatially coordinate the localization of relevant RhoGEFs and RhoGAPs to cadherin junctions. We now report that this involves an IIA and IIB at cell junctions in MCF-7 cells treated with dimethylsulphoxide (Ctrl) or nocodazole (Noc, 100 nM, 3 h). n = 25; * * * P < 0.001; NS, not significant; Student's t -test. (i,j) RhoA in control and nocodazole-treated cells. A representative apical confocal image is shown (i) with junctional RhoA fluorescence intensity (j). n = 30; * * * P < 0.001; NS, not significant; Student's t -test. (k,l) Effect of nocodazole on Rho-GTP in confluent MCF-7 cells. CFP and ratio of FRET/CFP representative images are shown (k) with average emission ratios quantified at the apical junctions (l). n = 40; * * * P < 0.001; Student's t -test. (m) Junctional Rho in MCF-7 cells transfected with pECFP-C1 (Ctrl) or with pSUPER constructs containing shRNAs against luciferase (Luc) or EB1 + EB3 (EB1/3 shRNA). n = 15; * * * P < 0.001; one-way analysis of variance (ANOVA), Dunnett's post hoc test. Heat colour scales in e and k for FRET/CFP emission ratios are shown. Data are control normalized means ± s.e.m. pooled from three individual experiments. Scale bars: 10 µm (a,c,i); 5 µm (b,e,k).
this was reduced by C3T ( Fig. 1e,g ). Thus, cadherin-based cell-cell junctions are prominent sites of Rho signalling in interphase epithelial cells. Mechanisms must then exist to ensure that Rho is activated, and maintained in an active state, at those junctions. Previously we demonstrated that cadherin junctions and their associated cytoskeleton are influenced by dynamic microtubules 18 . In particular, nocodazole, used at a concentration (100 nM) that blocks microtubule plus-end dynamics without depolymerizing the lattice 19, 20 , prevented the junctional accumulation of myosin IIA, but not that of myosin IIB ( Fig. 1h and Supplementary Fig. S1a ). As myosin IIA, but not myosin IIB (ref. 13) , requires Rho signalling to concentrate at the zonula adherens 13, 21 , this suggested that dynamic microtubule plusends might also regulate Rho. Indeed, nocodazole substantially reduced both junctional Rho (Fig. 1i,j) and Rho-GTP (Fig. 1k,l) . Junctional Rho ( Fig. 1m and Supplementary Fig. S1b ) and myosin IIA ( Supplementary  Fig. S1c ) were also decreased when dynamic microtubule plus ends were independently perturbed by depletion of end-binding (EB) proteins 1 and 3 ( Supplementary Fig. S1b ) 22, 23 . The zonula adherens thus seemed to be a microtubule-dependent Rho zone.
ECT2 activates Rho signalling at the zonula adherens
We then examined the cellular localization of microtubule-sensitive RhoGEFs. Strikingly, ECT2 (Fig. 2a,b) , but not GEF-H1 (not shown), was stained at junctions in interphase MCF-7 cells. ECT2 is a RhoGEF best understood to operate during mitosis, where it localizes to the contractile furrow ( Supplementary Fig. S2a ) and activates Rho 9, 24, 25 . With some exceptions 26 , it is reported to be a nuclear protein during interphase 24 , although these studies were generally performed in isolated cells that did not make adhesive contacts with one another. We found that although nuclear staining was detectable in confluent MCF-7 cells, ECT2 also clearly localized at cell-cell contacts (Fig. 2a) , an observation that we confirmed in Caco-2 and MDCK cells 26 ( Supplementary Fig. S2b ). Furthermore, ECT2 selectively localized to the zonula adherens within contacts (Fig. 2a,b) . The specificity of this staining pattern was confirmed by ECT2 RNA-mediated interference (RNAi; Supplementary Fig. S2c ,e) and further corroborated by transiently expressed GFP-ECT2, which also localized to cell-cell contacts ( Supplementary Fig. S2d ). Of note, the amount of junctional ECT2 staining was reduced by both nocodazole (Fig. 2c,d ) and EB1/3 short hairpin RNA (shRNA; Fig. 2e ). Thus, ECT2 was an attractive candidate to mediate microtubule-dependent Rho signalling at the zonula adherens.
To investigate this, we depleted ECT2 in MCF-7 cells by lentiviral shRNA (Fig. 2f) . Both junctional Rho (Fig. 2g,h ) and Rho-GTP (Fig. 2i,j) were reduced by ECT2 knockdown. Furthermore, both parameters were restored by expression of an RNAi-resistant transgene (Fig. 2g-j) , indicating that the changes in Rho signalling were due to loss of ECT2 itself. Junctional Rho was similarly reduced when ECT2 was depleted by short interfering RNA (siRNA; Supplementary Fig. S2e,f) . Together, these findings identify ECT2 as a major activator of Rho signalling at the zonula adherens.
ECT2 signalling regulates zonula adherens integrity and apical junction tension
The zonula adherens is a specialized adhesive junction that supports epithelial cohesion and apical contractility 27 . Its integrity requires Rho signalling to the actomyosin cytoskeleton 13, 28 . We found that ECT2 supports the zonula adherens. When compared with controls, ECT2-deficient cells failed to concentrate E-cadherin into the apical ring of the zonula adherens (Fig. 3a,b and Supplementary  Fig. S2g ), although cadherin clusters remained at the lateral contacts (Fig. 3a) . In contrast, tight junctions persisted in ECT2-knockdown cells ( Supplementary Fig. S3a,b) , indicating a relatively selective effect on the zonula adherens. As neither total nor surface levels of E-cadherin were altered by ECT2 knockdown (Supplementary Fig. S3c ), we postulated that the defect arose from failure of surface cadherin to be concentrated in an apical junctional structure. To investigate this, we expressed E-cadherin-EGFP in cadherin RNAi cells 29 and measured fluorescence recovery after photobleaching (FRAP) in the apical region. ECT2 knockdown and C3T both decreased the immobile fraction and the half-time of recovery (t 1/2 ; Fig. 3c and Supplementary Table S1), indicating more rapid turnover of apical E-cadherin. This implies that ECT2-Rho signalling stabilizes E-cadherin mobility at the apical junctional zone.
To better understand how ECT2 stabilizes cadherin, we then examined its effects on the junctional cytoskeleton. Surprisingly, F-actin staining at the zonula adherens was not altered by ECT2 RNAi or by C3T ( Supplementary Fig. S3d,e) . However, ECT2 RNAi depleted myosin IIA, but not myosin IIB, from apical junctions (Fig. 3d,e) . Myosin IIA depletion perturbs the zonula adherens in a very similar manner to ECT2 RNAi (ref. 13 ) and, indeed, myosin IIA shRNA also increased apical E-cadherin-EGFP mobility ( Fig. 3c and Supplementary Table S1 ). These findings thus suggested that ECT2 supports zonula adherens integrity through myosin IIA. If so, we predicted that junctional integrity might be restored in ECT2 shRNA cells if the amount of myosin IIA at the junctions could be increased. Indeed, the intensity of the E-cadherin fluorescence signal was increased in ECT2 knockdown cells by expression of GFP-myosin IIA (Fig. 3f,g ). As Rho is necessary for myosin IIA to concentrate at the zonula adherens 13 and acute treatment with C3T displaced myosin IIA, but not ECT2, from junctions ( Fig. 3h,i) , ECT2 presumably recruits myosin IIA indirectly by activating Rho.
The coordination of actomyosin contractility with cadherin adhesion can also generate tension at the zonula adherens 30 , which influences cell-cell movements and patterning within epithelia 31, 32 . To determine whether ECT2 signalling affects junctional tension, we used a femtosecond laser to cut junctions and measured the instantaneous recoil of their vertices as an index of tension 32 . Junctional tension was reduced by ECT2 knockdown and also when its downstream targets were inhibited by C3T and myosin IIA RNAi (Fig. 3j,k and Supplementary Fig. S3f) .
Overall, these findings identify an extra-mitotic role for ECT2 to support cell-cell interactions between interphase epithelial cells. We propose that selective localization of ECT2 to the zonula adherens promotes local Rho signalling. This ultimately signals to recruit and activate myosin IIA (refs 13,21) , which stabilizes apical cadherin to preserve the integrity of the zonula adherens and support junctional tension.
The centralspindlin complex mediates microtubule-dependent junctional localization of ECT2
To better understand how dynamic microtubules influence junctional ECT2 we measured FRAP of junctional GFP-ECT2 expressed in ECT2 RNAi cells (Fig. 4a) . Nocodazole reduced the immobile fraction, without significantly affecting t 1/2 , suggesting that dynamic microtubules might influence cortical binding of ECT2 at junctions. In parallel, we screened ECT2 immunoprecipitates by mass spectrometry to identify potential junctional binding partners (not shown). Amongst these we found the kinesin, MKLP1, a component of the centralspindlin complex, which also contains MgcRacGAP, a direct binder of ECT2 (ref. 33) . During cytokinesis centralspindlin localizes ECT2 to activate Rho at the contractile furrow 9,25 and we therefore wondered whether it might play a similar role at the zonula adherens during interphase.
Indeed, both MgcRacGAP and MKLP1 localized to microtubuledense MCF-7 cell-cell junctions, as well as in nuclei, as has been previously reported in isolated cells 34 ( Fig. 4b and Supplementary  Fig. S4a ). Of note, like ECT2 (Fig. 2a) , both centralspindlin components selectively concentrated with E-cadherin in the zonula adherens (shown for MgcRacGAP in Fig. 4b ). RNAi of either protein abolished its junctional staining ( Supplementary Fig. S4b ,c) and junctional localization was further confirmed by GFP-tagged MgcRacGAP and MKLP1 ( Supplementary Fig. S4d ). Centralspindlin is thus a junctional constituent in interphase MCF-7 cells.
We then used RNAi ( Supplementary Fig. S4b ) to assess whether centralspindlin affected junctional ECT2 and Rho signalling. MgcRacGAP or MKLP1 siRNA substantially reduced junctional ECT2 (Fig. 4c,d ) but not its total expression (Fig. 4e) , whereas ECT2 RNAi did not affect junctional centralspindlin ( Supplementary Fig. S4e ). This suggested that centralspindlin influences the junctional localization of ECT2, analogous to its action during cytokinesis 9, 25 . Furthermore, the amount of junctional Rho was reduced by either MKLP1 or MgcRacGAP knockdown (Fig. 4f,g ) and the amount of Rho-GTP was reduced by MgcRacGAP depletion (Fig. 4h) . Myosin IIA was also selectively lost from junctions in centralspindlin-depleted cells ( Fig. 4i and Supplementary Fig. S4f ). Supporting a central role for centralspindlin in junctional signalling, the integrity of the zonula adherens was perturbed in both MKLP1 and MgcRacGAP knockdown cells ( Fig. 4j and Supplementary Fig. S4f ). Interestingly, junctional localization of centralspindlin was reduced by 100 nM nocodazole (Fig. 4k ,l), making it an attractive candidate to mediate the microtubule-dependent localization of ECT2 to junctions. Indeed, the nocodazole sensitivity of junctional ECT2 was abolished by MgcRacGAP RNAi (Fig. 4m) . Overall, these data implicate centralspindlin in localizing ECT2 to the zonula adherens.
α-catenin localizes ECT2 to the zonula adherens through centralspindlin
Binding to centralspindlin alone did not readily explain the specific localization of ECT2 to the zonula adherens. We were thus interested to also identify α-catenin in our ECT2 interaction screen (not shown), a finding confirmed by reciprocal co-immunoprecipitation analysis (Fig. 5a ). E-cadherin also co-precipitated with ECT2 and α-catenin ( Fig. 5a ) suggesting that these proteins might exist in a complex. Consistent with this, ECT2, α-catenin and E-cadherin co-localized, principally at the zonula adherens ( Fig. 5b and Supplementary Fig. S5a ).
We then depleted α-catenin by siRNA ( Supplementary Fig. S5b ) and examined cells after 24 h, when junctional α-catenin was significantly diminished, but cell-cell contacts remained intact (Fig. 5b) . The amount of junctional ECT2 (Fig. 5b,c ) and the biochemical association of E-cadherin with ECT2 ( Fig. 5d ) were both significantly reduced in α-catenin knockdown cells. Thus, α-catenin also contributes to the junctional localization of ECT2. (m) MCF-7 cells were transfected with siRNA against MgcRacGAP or scrambled (control) siRNA and were incubated with 100 nM nocodazole (3 h) or dimethylsulphoxide (Ctrl), after which nocodazole was washed out and cells were allowed to recover (Noc w.o, 1 h). ECT2 staining was quantified by line scan analysis. n = 15; * * * P < 0.001; NS, not significant; one-way ANOVA, Bonferroni post hoc test, to compare across all data sets. Unless otherwise stated, data are control-normalized mean ± s.e.m. pooled from three individual experiments. Scale bars, 10 µm (c, and b,k for MgcRacGAP); 5 µm (f, and b,k for MKLP1). Uncropped images of blots are shown in Supplementary Fig. S8 .
We then examined whether centralspindlin was involved in the interaction between α-catenin and ECT2. MgcRacGAP immunoprecipitated with both E-cadherin and α-catenin (Fig. 6a) and MgcRacGAP knockdown significantly reduced the amount of ECT2 that co-immunoprecipitated with α-catenin (Fig. 6b) , without affecting the E-cadherin-α-catenin interaction (Fig. 6c) . This implied that centralspindlin serves as an intermediate to localize ECT2 to α-catenin at the zonula adherens. Consistent with this, α-catenin knockdown substantially reduced the amount of both junctional MgcRacGAP and MKLP1 (Fig. 6d,e) but MgcRacGAP knockdown had only a minor impact on the amount of junctional α-catenin (Fig. 6f,g ) probably owing to loss of the mature zonula adherens. Furthermore, nocodazole reduced the level of interaction between MgcRacGAP and α-catenin (Fig. 6h) , suggesting that dynamic microtubules might regulate this interaction to support junctional ECT2.
To better characterize the molecular basis of these interactions, we expressed GFP-tagged α-catenin mutants in HEK293 cells (Fig. 6i and Supplementary Fig S5d) . Both endogenous ECT2 and MgcRacGAP consistently co-precipitated with full-length α-catenin and with amino-terminal fragments of α-catenin (1-290, 1-507), but not with a carboxy-terminal fragment (507-906). Thus, the N terminus of α-catenin seems to mediate its association with centralspindlin and ECT2. We therefore conclude that α-catenin serves as a cortical anchor for centralspindlin at the zonula adherens, to thereby support the ECT2-Rho signalling pathway.
This model further predicted that α-catenin would influence junctional Rho signalling. Indeed, the amounts of junctional Rho (Fig. 5e,f) , Rho-GTP (Fig. 5g,h ) and myosin IIA, but not myosin IIB (Supplementary Fig. S5c ), were reduced in α-catenin knockdown cells.
Centralspindlin inhibits the junctional recruitment of p190B RhoGAP
Finally, we investigated whether centralspindlin might also influence junctional Rho by regulating its inactivation, as the spatial expression of Rho-GTP is influenced by the localized action of RhoGAPs as well as by RhoGEFs (refs 3,35) . We focused on p190RhoGAP, which has been implicated in cadherin junctions 36, 37 and in regulating Rho signalling at the cytokinetic furrow 35, 38, 39 . Two members of this protein family exist in mammals 40, 41 and both p190A RhoGAP and p190B RhoGAP were detected in MCF-7 cells (Fig. 7f) . In control MCF-7 monolayers, staining for both these proteins was predominantly cytoplasmic, with little apparent at junctions (Fig. 7a) . Strikingly, however, junctional p190B RhoGAP, but not p190A RhoGAP, became evident after nocodazole treatment (Fig. 7b,c) . This suggested that dynamic microtubules might specifically inhibit the junctional accumulation of p190B RhoGAP.
As dynamic microtubules support the junctional localization of the centralspindlin complex, we then investigated whether centralspindlin influenced junctional p190B RhoGAP. Indeed, junctional p190B RhoGAP staining was significantly increased by either MgcRacGAP or MLKP1 knockdown but not by ECT2 RNAi (Fig. 7d,e) . Together, these data suggested that the microtubule-dependent localization of centralspindlin at the zonula adherens might also promote junctional Rho-GTP by blocking recruitment of p190B RhoGAP, as well as through local activation of Rho by ECT2.
We investigated this by examining whether the increased p190B RhoGAP contributed to the reduced Rho found at junctions in nocodazole-treated cells. This hypothesis predicted that reducing p190B RhoGAP should decrease the impact of nocodazole on junctional Rho. Accordingly, we selectively depleted p190B RhoGAP by siRNA (Fig. 7f) . Nocodazole reduced junctional Rho and Rho-GTP in cells transfected with control siRNAs (Fig. 7g-i) , exactly as it did in untransfected cells (Fig. 1i-l) . Strikingly, however, nocodazole did not reduce junctional Rho (Fig. 7g,h ) or Rho-GTP (Fig. 7i) to the same level in p190B RhoGAP knockdown cells as it did in control cells. This implies that p190B RhoGAP contributed to the inhibition of Rho by nocodazole. p190B RhoGAP contains a GTP-Rac binding domain that regulates its cortical recruitment 40 . As cell-cell contacts can be sites of Rac signalling 7 , we therefore investigated whether p190B RhoGAP was recruited to junctions in response to Rac. Indeed, the junctional accumulation of p190B RhoGAP induced by nocodazole was reduced by the expression of dominant-negative Rac (N17; Fig. 7j ) or treatment with the Rac inhibitor NSC 23766 (Supplementary Fig. S6b ). Furthermore, a p190B RhoGAP mutant lacking the Rac-interaction domain 40 did not localize to junctions in nocodazole-treated cells (Supplementary Fig. S6a) . Thus, the nocodazole-induced recruitment of p190B RhoGAP seems to require Rac signalling. Potentially, then, the microtubule-centralspindlin pathway may block p190B RhoGAP recruitment by inhibiting junctional Rac. Indeed, using a Raichu-Rac FRET biosensor we found that junctional GTP-Rac was increased both by nocodazole and MgcRacGAP knockdown ( Fig. 7k and Supplementary Fig. S6c ). Together, these results suggest that centralspindlin may inhibit junctional p190B RhoGAP recruitment by reducing the level of junctional Rac signalling.
DISCUSSION
In sum, our findings identify the epithelial zonula adherens as a Rho zone that is an interphase equivalent of the Rho zone of the cytokinetic furrow 8, 9 . Like the cytokinetic furrow, the Rho zone of the zonula adherens serves to concentrate actomyosin, acting through myosin IIA to maintain the integrity of the junction itself. Remarkably, Rho signalling at the zonula adherens is controlled by many of the same molecules that regulate Rho at the cytokinetic furrow. The key role is played by the centralspindlin complex, which supports the junctional Rho zone by regulating both the activation and inactivation limbs of the GTPase cycle: it activates Rho by recruiting the RhoGEF ECT2 and prevents Rho inhibition by blocking the junctional recruitment of p190B RhoGAP (Supplementary Fig. S7 ). Recruitment of ECT2 may reflect its known direct interaction with MgcRacGAP (refs 9,25) and we postulate that centralspindlin blocks p190B RhoGAP recruitment by directly or indirectly inhibiting junctional Rac (ref. 40) . Of note, both ECT2 and p190 RhoGAP have also been implicated in Rho regulation at the cytokinetic furrow 9, 25, 35, 39 , although other GAPs, including MgcRac-GAP itself 3 , may also contribute. Thus, the Rho zone of the zonula adherens reflects the action during interphase of a conserved molecular ensemble that can translate coordinated regulation of the Rho GTPase cycle into spatial expression of an active Rho signal at the junction. From this perspective, a key issue is what localizes centralspindlin to the zonula adherens. Here we found that α-catenin supports the cortical binding of centralspindlin, and thereby ECT2, at the zonula adherens. This implies that α-catenin can influence cadherin biology by regulating Rho signalling at the zonula adherens. Consistent with this, α-catenin knockdown reduced both Rho signalling and the cortical recruitment of myosin IIA. Of note, too, these effects were observed under conditions of incomplete α-catenin depletion; at later times after siRNA transfection, cells detached from one another, a more extreme phenotype that may reflect the other pathways by which α-catenin can affect cadherin function 42, 43 . Thus, Rho regulation may be a relatively sensitive effect of α-catenin on cadherin biology. Interestingly, Drosophila α-catenin has been reported to associate with Rho itself 10 , suggesting that multiple mechanisms may exist to allow α-catenin to regulate Rho signalling at cadherin junctions.
It was striking that both centralspindlin and ECT2 selectively localized to the zonula adherens. Moreover, ECT2 and the centralspindlin complex seemed to selectively support zonula adherens integrity, whereas tight junctions remained morphologically intact in ECT2 and centralspindlin knockdown cells. In contrast, p114 RhoGEF, which is recruited to tight junctions through an association with cingulin 44 , supports tight junctions but not cadherin-based adhesive junctions. Different GEFs may then control different pools of Rho to support different junctions within the apical junctional complex and elsewhere in the contact zone between cells. Such a conclusion is consistent with the general paradigm that the action of specific GEFs may allow the common Rho signal to be used for different functional outcomes 1, 40 . Furthermore, although α-catenin was necessary to localize centralspindlin and ECT2 to the zonula adherens, it is noteworthy that α-catenin also distributes with E-cadherin more extensively outside the zonula adherens itself. Thus, centralspindlin is unlikely to associate constitutively with α-catenin. Instead, other as yet unknown factors must collaborate to confer specificity for this interaction on the pool of α-catenin associated with the zonula adherens itself.
Finally, our experiments also identify a role for dynamic microtubules to affect Rho signalling at the zonula adherens, apparently by influencing the capacity of the junctional cortex to bind ECT2. Dynamic microtubules seemed to regulate the association between centralspindlin and α-catenin, but not the catenin-cadherin interaction (not shown). The detailed mechanism responsible for this effect remains to be clarified. During cytokinesis it has been proposed that centralspindlin mediates the microtubule-dependent delivery of ECT2 to cytokinetic furrows 45 . Cell-cell junctions are regions that interact with and regulate microtubules 15, 46, 47 , including a subpopulation that extend with their dynamic plus-ends directed towards the junctional cortex 18 . Such dynamic microtubules could facilitate the delivery of centralspindlin by microtubule-dependent transport 48 or by serving as diffusional traps 47 at the cortex. However, so far we have been unable to demonstrate microtubule-dependent transport of centralspindlin or ECT2 (not shown). Alternatively, dynamic microtubules might affect the binding of centralspindlin to α-catenin indirectly, through cortical signalling 49 . These signals may include post-translational modifications, such protein phosphorylation, which influences ECT2 activation and its interaction with centralspindlin during cytokinesis 50 . Whether some of these pathways are also reused at the zonula adherens will be an important issue for future research.
METHODS
Methods and any associated references are available in the online version of the paper. IIA) and Ecad-GFP (refs 13,29) have been described previously. Full-length mouse α-catenin was initially cloned into pEGFP-C2 vector and mouse α-catenin deletion mutants were cloned into pEGFP-C1 vector using EcoRI and SalI sites. Truncation mutants were created by PCR mutagenesis based on the secondary structure of α-catenin.
Mass Spectrometry. Mass spectrometry was performed as previously described 53 .
siRNA and shRNA knockdowns. A lentivirus-based shRNA system 54, 55 was used to deplete ECT2 in MCF-7 cells. The lentivirus expression vector LentiLox pLL5.0 (backbone pLL3.7) and the third-generation packaging constructs pMDLg/pRRE, RSV-Rev and pMD.G were gifts from J. Bear 55 (UNC Chapel Hill, USA). Algorithms from Dharmacon were used to predict sequences that would lead to silencing of human ECT2 (NM_018098). Predicted sequences were used to design shRNAs containing a stem loop sequence based on previous studies 56 , and these were cloned into pLL5.0 yielding pLL5.0 Cherry-shECT2. In brief, shRNA was cloned downstream of the U6 promoter (HpaI and XhoI) into a modified version of pLL5.0 carrying a soluble cherry as a reporter gene (pLL5.0 Cherry-shECT2). To reconstitute full-length ECT2 in the same vector, the ECT2 coding sequence was amplified and cloned into the BsrGI site of pLL5.0 Cherry-shECT2 (pLL5.0 mCherry-shRNA resistant ECT2). Alternatively, to reconstitute GFP-tagged shRNA-resistant ECT2 in an ECT2 knockdown background, the mCherry reporter was replaced by a sequence encoding GFP from pEGFP-C1 and then the ECT2 coding sequence was cloned into the vector using EcoR1 and BamH1 sites (pLL5.0 GFP-shRNA resistant ECT2).
The generation and titre of lentivirus stocks has been described previously 13 . MCF-7 cells were infected with lentiviral particles at a multiplicity of infection of 10 per cell as described previously 13 and used within the first week after infection. siRNA and shRNA sequences are shown in Supplementary Table S2 .
Antibodies, immunoprecipitations and inhibitors. Primary antibodies used
in this study are shown in Supplementary Table S3 . Secondary antibodies were species-specific antibodies conjugated with AlexaFluor 488, 594 or 647 (Invitrogen; 1:500) and F-actin was stained with AlexaFluor 488-phalloidin or 594-phalloidin (1:1,000 dilution; Invitrogen).
For each immunoprecipitation assay, ∼2 mg of total protein was used, and 2 µg of antibody and 20 ml packed slurry of Protein A or 15 ml packed slurry of GFP-Trap coupled to agarose beads (Chromotek) were added. Surface trypsin sensitivity assays were carried out as described previously 57 . Nocodazole (Sigma Aldrich) was used at 100 nM and the Rho inhibitor CT04 (Cytoskeleton) was used at 0.250 µg ml −1 . The Rac inhibitor NSC 23766 (Sigma Aldrich) was used at 50 µM.
Immunofluorescence microscopy. Cells were fixed with 10% TCA on ice for 15 min for RhoA staining or with 4% paraformaldehyde in PBS at 22 • C for 20 min for F-actin staining, and were then permeabilized with 0.25% Triton-X100 in PBS for 5 min at room temperature. Otherwise, cells were fixed with ice-cold methanol for 5 min on ice.
Wide-field images were acquired with either an IX81 Olympus epi-illumination microscope (×60 and ×100, 1.4 numerical aperture (NA) objectives) and a Hamamatsu Orca-1 ER camera driven by Metamorph imaging software (version 7; Universal Imaging) or a Personal Deltavision deconvolution microscope (Applied Precision, ×60, 1.4 NA objectives) and a Roper Coolsnap HQ2 monochrome camera. Confocal images were captured with a Zeiss 510 or a Zeiss 710 Meta laser-scanning confocal microscope, and z-stacks were processed with ImageJ (National Institutes of Health) software. Background correction, contrast adjustment and z-projections of raw data images were performed with ImageJ, Imaris (Bitplane) or Photoshop (Adobe).
Quantification of fluorescence intensity at contacts. The fluorescence intensity at contacts was quantified using the line scan function in ImageJ as described earlier 13 . Up to 50 contacts were measured, derived from three different experiments. To quantify MgcRacGAP or MKLP1 at contacts (Supplementary Fig. S4e ), the number of contacts that were positive for the protein was normalized to the total number of contacts. Up to 180 contacts were counted in each experiment and the data from three different experiments were pooled. Data were normalized to control values.
FRET microscopy. MCF-7 cells were transiently transfected with the following constructs; RhoA biosensor 4 ; RhoA biosensor with either pLL5.0 Cherry-shECT2 or pLL5.0 mCherry-shRNA-resistant ECT2; Raichu-Rac biosensors 52 . For siRNA experiments, the biosensor was co-transfected with the indicated siRNA and FRET measurements were performed 48 h after transfection. Cells were imaged live at 37 • C by confocal microscopy and images were acquired on an LSM 710 Zeiss confocal microscope equipped with a ×63 oil immersion objective (Plan Apochromat ×63 1.4 NA, Zeiss). Donor and FRET channels were recorded by scanning using a 458 nm laser line and collecting the emission in the donor emission region (BP 470-490 nm) and acceptor emission region (BP 530-590 nm), respectively. In addition, crosstalk and acceptor channels were collected using the 514 nm laser line for excitation and collecting the emission in the donor and acceptor emission regions. Where necessary, a third scan was included to acquire the mCherry fluorescence signal (mCherry channel) using a 561 nm laser line and fluorescence signal was collected in the region 590-620 nm.
A modified version of the FRET emission ratio method 4 was used to calculate this parameter on a pixel-by-pixel basis. The FRET index was calculated for every image as the average (FRET/donor) emission ratio for pixels located in the selected regions of interest (ROIs). FRET values were calculated for the cell-cell junctions and cytosolic regions independently and were normalized to the value corresponding to the average FRET emission ratio value observed at the cell-cell contacts in control conditions. Data presented are mean FRET emission ratios calculated across the different images and their standard errors.
FRAP. FRAP experiments were performed either on an LSM 510 or LSM 710 meta
Zeiss confocal microscope with a heated stage maintained at 37 • C. Images were acquired using a ×63 objective, 1.4 NA oil Plan Apochromat immersion lens at ×4 digital magnification.
To assess E-cadherin dynamics, a vector that allows simultaneous expression of a shRNA specific for human E-cadherin and full-length mouse E-cadherin-EGFP (E-cad-GFP; ref. 29) and pLL5.0 Cherry-shECT2 were introduced into MCF-7 cells by lentivirus and cells analysed after 24 h. A constant ROI in the centre of the cell-cell contact was bleached to ∼70% with a 488 nm laser at 100%. Time-lapse images were acquired before and after photobleaching with an interval of ∼5 s per frame for a total of 280 s. Image analysis was performed using ImageJ. To calculate FRAP profiles, a ROI at the bleached GFP-E-cadherin area was marked and the plug-in FRAP profiler (McMaster University) was applied to obtain fluorescence intensity profiles, F (t ). Fluorescence intensities were normalized to prebleach values F (−t ) and fitted to the equation:
where F(t) is the average fluorescence of the ROI, Mf is the mobile fraction, t 1/2 is the half-time of recovery and t is time in seconds. ECT2 dynamics were assessed using EGFP-ECT2 expressed with ECT2 shRNA by lentiviral infection. A constant circular ROI in the centre of the cell-cell contact was bleached to ∼70% with 488 and 405 nm lasers at 100%. Time-lapse images of the same were acquired before (20 frames, 5 s) and after (210 frames, 50 s) photobleaching with an interval of ∼250 ms per frame. Image analysis was performed using ImageJ. To calculate FRAP profiles, a ROI at the bleached GFP-ECT2 area was marked and its average fluorescence intensity was determined at every time point. Fluorescence intensities were normalized to average prebleach values F (−t ) and fitted to the double exponential equation:
where F (t ) is the average fluorescence of the ROI, Mf is the mobile fraction, f fast and f slow are weighting factors for fast and slow mobile components, t Laser nanoscissors. Ablation experiments were performed on an LSM 510 meta
Zeiss confocal microscope at 37 • C. Images were acquired using a ×63 objective, 1.4 NA oil Plan Apochromat immersion lens at ×1.5 digital magnification, with the pinhole adjusted to 3 Airy units to obtain optical sections 2 µm thick. Time-lapse images were acquired before (3 frames) and after (4 frames) ablation with an interval of 15 s per frame. For ablation, a Ti:sapphire laser (Chameleon Ultra, Coherent Scientific) tuned to 790 nm was used to ablate cell contacts identified with E-cadherin-GFP fluorescence emission. A constant ROI was marked for each experiment and ablated with 30 iterations of a 790 nm laser with 50% transmission. GFP fluorescence intensity was determined before and after the induced ablation using a 488 nm laser for excitation and a 500-550 nm emission filter. 
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